CERT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Certara Inc (CERT) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock has weak financial performance, mixed analyst ratings, and lacks positive momentum or clear trading signals. Holding off on investment until clearer growth trends or positive catalysts emerge is recommended.
The MACD is positive but contracting, RSI is neutral at 25.83, and moving averages are converging. The stock is trading near its support level (S1: 6.485), with resistance at 7.41. No strong bullish or bearish signals are present.
UBS and TD Cowen maintain Buy ratings, citing Certara's unique position in model-informed drug development. Gross margin improved slightly YoY.
Q4 financials showed a net income drop of -189.63% YoY and EPS decline of -200.00% YoY. Analysts have lowered price targets, with some downgrading the stock to Neutral or Hold. Lack of recent news or significant insider/hedge fund activity.
In Q4 2025, revenue grew by 3.28% YoY, but net income dropped significantly to -$5.9M, and EPS fell to -0.04. Gross margin increased slightly to 48.26%. Overall, financial performance is weak.
Analysts have mixed views. UBS and TD Cowen maintain Buy ratings but lowered price targets to $10. Barclays downgraded the stock to Equal Weight, citing concerns about growth acceleration. Other firms have also reduced price targets, reflecting uncertainty about the company's near-term prospects.
